This is research from the Leeds Institute of Rheumatic and Musculoskeletal Medicine and others which found that MTX provided significant pain reduction after 6 months,
pubmed.ncbi.nlm.nih.gov/390...
Many PMR patients with OA seem to find considerable relief with pred but then become aware of the OA as they get to lower doses. Many rheumies are very keen to add MTX if they feel patients aren't progressing with their tapering as well as they would like and sometimes there is great difficulty deciding if the returning pain is due to incompletely managed PMR or OA or both.
Some patients with PMR do respond extremely well to the addition of MTX but you have to try it to find out if you are one. MTX is standard management for inflammatory arthritis and, as shown here, also potentially for OA and sometimes, we know, for PMR. Quite a few patients do develop signs of peripheral arthritis alongside and possibly part of their PMR.
If you are offered MTX and agree to trial it and find that you are one of the many who can take it without too many adverse effects, this could well be a game changer, working for 3 different conditions at the same time.